{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:08:20Z","timestamp":1787170100955,"version":"build-2736575974"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.19041","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T18:04:33Z","timestamp":1585850673000},"page":"124-129","source":"Crossref","is-referenced-by-count":13,"title":["Differential diagnosis of chronic lymphocytic leukemia\/small                    lymphocytic lymphoma and other indolent lymphomas, including mantle cell                    lymphoma"],"prefix":"10.3960","volume":"60","author":[{"given":"Tadashi","family":"Yoshino","sequence":"first","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School,                            Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School,                            Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School,                            Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Campo E, Chia P, Montserrat E, et al.                    Chronic lymphocytic leukaemia \/ small lymphocytic lymphoma. In: Swerdlow SH,                    Campo E, Harris NL <i>et al<\/i>. (eds). WHO Classification of Tumours.                    4th ed, Lyon, IARC Press. 2017; pp. 216-221."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Menter                            T,                                Trivedi                            P,                                Ahmad                            R                    <i>et al.<\/i> Diagnostic utility of lymphoid enhancer binding factor 1                    immunohistochemistry in small B-cell lymphomas. Am J Clin Pathol. 2017; 147:                    292-300.","DOI":"10.1093\/ajcp\/aqw208"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 O\u2019Malley                            DP,                                Lee                            JP,                                Bellizzi                            AM. Expression                    of LEF1 in mantle cell lymphoma. Ann Diagn Pathol. 2017; 26: 57-59.","DOI":"10.1016\/j.anndiagpath.2016.09.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Saksena                            A,                                Yin                            CC,                                Xu                            J                    <i>et al.<\/i> CD23 expression in mantle cell lymphoma is associated                    with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum                    Pathol. 2019; 89: 71-80.","DOI":"10.1016\/j.humpath.2019.04.010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ye                            H,                                Desai                            A,                                Zeng                            D                    <i>et al.<\/i> Smoldering mantle cell lymphoma. J Exp Clin Cancer Res.                    2017; 36: 185.","DOI":"10.1186\/s13046-017-0652-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hu                            Z,                                Sun                            Y,                                Schlette                            EJ                    <i>et al.<\/i> CD200 expression in mantle cell lymphoma identifies a                    unique subgroup of patients with frequent IGHV mutations, absence of SOX11                    expression, and an indolent clinical course. Mod Pathol. 2018; 31: 327-336.","DOI":"10.1038\/modpathol.2017.135"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 J\u00e9gouzo                            SAF,                                Feinberg                            H,                                Morrison                            AG                    <i>et al.<\/i> CD23 is a glycan-binding receptor in some mammalian                    species. J Biol Chem. 2019; 294: 14845-14859.","DOI":"10.1074\/jbc.RA119.010572"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kriston                            C,                                B\u00f6d\u00f6r                            C,                                Szenthe                            K                    <i>et al.<\/i> Low CD23 expression correlates with high CD38 expression                    and the presence of trisomy 12 in CLL. Hematol Oncol. 2017; 35: 58-63.","DOI":"10.1002\/hon.2244"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Baumgarth                            N. A hard(y)                    look at B-1 cell development and function. J Immunol. 2017; 199: 3387-3394.","DOI":"10.4049\/jimmunol.1700943"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Jaso                            J,                                Chen                            L,                                Li                            S                    <i>et al.<\/i> CD5-positive mucosa-associated lymphoid tissue (MALT)                    lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. 2012; 43:                    1436-1443.","DOI":"10.1016\/j.humpath.2011.11.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Jaso                            JM,                                Yin                            CC,                                Wang                            SA                    <i>et al.<\/i> Clinicopathologic features of CD5-positive nodal                    marginal zone lymphoma. Am J Clin Pathol. 2013; 140: 693-700.","DOI":"10.1309\/AJCPEMVXES72DUIF"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kojima                            M,                                Sato                            E,                                Oshimi                            K                    <i>et al.<\/i> Characteristics of CD5-positive splenic marginal zone                    lymphoma with leukemic manifestation; clinical, flow cytometry, and                    histopathological findings of 11 cases. J Clin Exp Hematop. 2010; 50: 107-112.","DOI":"10.3960\/jslrt.50.107"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Falini                            B,                                Agostinelli                            C,                                Bigerna                            B                    <i>et al.<\/i> IRTA1 is selectively expressed in nodal and extranodal                    marginal zone lymphomas. Histopathology. 2012; 61: 930-941.","DOI":"10.1111\/j.1365-2559.2012.04289.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Li                            Y,                                Hu                            S,                                Zuo                            Z                    <i>et al.<\/i> CD5-positive follicular lymphoma: clinicopathologic                    correlations and outcome in 88 cases. Mod Pathol. 2015; 28: 787-798.","DOI":"10.1038\/modpathol.2015.42"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Treon                            SP,                                Xu                            L,                                Yang                            G                    <i>et al.<\/i> MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s                    macroglobulinemia. N Engl J Med. 2012; 367: 826-833.","DOI":"10.1056\/NEJMoa1200710"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yu                            X,                                Li                            W,                                Deng                            Q                    <i>et al.<\/i> MYD88 L265P mutation in lymphoid malignancies. Cancer                    Res. 2018; 78: 2457-2462.","DOI":"10.1158\/0008-5472.CAN-18-0215"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Taniguchi                            K,                                Takata                            K,                                Chuang                            SS                    <i>et al.<\/i> Frequent MYD88 L265P and CD79B mutations in primary                    breast diffuse large B-Cell lymphoma. Am J Surg Pathol. 2016; 40: 324-334.","DOI":"10.1097\/PAS.0000000000000592"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nagakita                            K,                                Takata                            K,                                Taniguchi                            K                    <i>et al.<\/i> Clinicopathological features of 49 primary                    gastrointestinal diffuse large B-cell lymphoma cases; comparison with location,                    cell-of-origin, and frequency of MYD88 L265P. Pathol Int. 2016; 66: 444-452.","DOI":"10.1111\/pin.12439"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/4\/60_19041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T23:31:01Z","timestamp":1608334261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/4\/60_19041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.19041","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}